They promise the benefits of some popular GLP-1 medications like Wegovy and Zepbound without injections
Participants were required to maintain the original diet, exercise and lifestyle during the trial
This breakthrough treatment reduces appetite and increases feelings of fullness by mimicking the GLP-1/ GIP hormone, which regulates glucose levels and insulin secretion
The FDA provided a grace period: 503A pharmacies had until February 18, 2025, and 503B outsourcing facilities until March 19, 2025
Ships to AK, AR, AZ, CO, CT, DE, FL, GA, KY, IA, ID, IL, IN, ME, MI, MN, MO, MT, NV, NY, OH, OK, OR, PA, SC, RI, TN, TX, UT, VA, VT, WA, WI, WV, WY